| . | . | Total Patients, n = 463 . | Age, mean ± SD, y . |
|---|---|---|---|
| Sex | |||
| Male | 272 (58.7%) | 52.7 ± 15.3 | |
| Female | 191 (41.3%) | 51.6 ± 14.1 | |
| WHO grade and IDH | |||
| II | Wildtype | 17 (3.7%) | 48.7 ± 16.3 |
| Mutant | 15 (3.2%) | 44.3 ± 10.9 | |
| III | Wildtype | 60 (13.0%) | 52.2 ± 15.2 |
| Mutant | 82 (17.7%) | 40.9 ± 10.2 | |
| IV | Wildtype | 261 (56.4%) | 57.5 ± 13.5 |
| Mutant | 28 (6.0%) | 43.4 ± 13.9 | |
| WHO grade and 1p/19q | |||
| II | Codeleted | 7 (1.5%) | 41.4 ± 10.8 |
| Non-codeleted | 25 (5.4%) | 48.1 ± 14.6 | |
| III | Codeleted | 41 (8.9%) | 42.2 ± 9.3 |
| Non-codeleted | 101 (21.8%) | 47.1 ± 14.9 | |
| IV | Codeleted | 8 (1.7%) | 54.6 ± 16.7 |
| Non-codeleted | 281 (60.7%) | 56.1 ± 14.1 |
| . | . | Total Patients, n = 463 . | Age, mean ± SD, y . |
|---|---|---|---|
| Sex | |||
| Male | 272 (58.7%) | 52.7 ± 15.3 | |
| Female | 191 (41.3%) | 51.6 ± 14.1 | |
| WHO grade and IDH | |||
| II | Wildtype | 17 (3.7%) | 48.7 ± 16.3 |
| Mutant | 15 (3.2%) | 44.3 ± 10.9 | |
| III | Wildtype | 60 (13.0%) | 52.2 ± 15.2 |
| Mutant | 82 (17.7%) | 40.9 ± 10.2 | |
| IV | Wildtype | 261 (56.4%) | 57.5 ± 13.5 |
| Mutant | 28 (6.0%) | 43.4 ± 13.9 | |
| WHO grade and 1p/19q | |||
| II | Codeleted | 7 (1.5%) | 41.4 ± 10.8 |
| Non-codeleted | 25 (5.4%) | 48.1 ± 14.6 | |
| III | Codeleted | 41 (8.9%) | 42.2 ± 9.3 |
| Non-codeleted | 101 (21.8%) | 47.1 ± 14.9 | |
| IV | Codeleted | 8 (1.7%) | 54.6 ± 16.7 |
| Non-codeleted | 281 (60.7%) | 56.1 ± 14.1 |
| . | . | Total Patients, n = 463 . | Age, mean ± SD, y . |
|---|---|---|---|
| Sex | |||
| Male | 272 (58.7%) | 52.7 ± 15.3 | |
| Female | 191 (41.3%) | 51.6 ± 14.1 | |
| WHO grade and IDH | |||
| II | Wildtype | 17 (3.7%) | 48.7 ± 16.3 |
| Mutant | 15 (3.2%) | 44.3 ± 10.9 | |
| III | Wildtype | 60 (13.0%) | 52.2 ± 15.2 |
| Mutant | 82 (17.7%) | 40.9 ± 10.2 | |
| IV | Wildtype | 261 (56.4%) | 57.5 ± 13.5 |
| Mutant | 28 (6.0%) | 43.4 ± 13.9 | |
| WHO grade and 1p/19q | |||
| II | Codeleted | 7 (1.5%) | 41.4 ± 10.8 |
| Non-codeleted | 25 (5.4%) | 48.1 ± 14.6 | |
| III | Codeleted | 41 (8.9%) | 42.2 ± 9.3 |
| Non-codeleted | 101 (21.8%) | 47.1 ± 14.9 | |
| IV | Codeleted | 8 (1.7%) | 54.6 ± 16.7 |
| Non-codeleted | 281 (60.7%) | 56.1 ± 14.1 |
| . | . | Total Patients, n = 463 . | Age, mean ± SD, y . |
|---|---|---|---|
| Sex | |||
| Male | 272 (58.7%) | 52.7 ± 15.3 | |
| Female | 191 (41.3%) | 51.6 ± 14.1 | |
| WHO grade and IDH | |||
| II | Wildtype | 17 (3.7%) | 48.7 ± 16.3 |
| Mutant | 15 (3.2%) | 44.3 ± 10.9 | |
| III | Wildtype | 60 (13.0%) | 52.2 ± 15.2 |
| Mutant | 82 (17.7%) | 40.9 ± 10.2 | |
| IV | Wildtype | 261 (56.4%) | 57.5 ± 13.5 |
| Mutant | 28 (6.0%) | 43.4 ± 13.9 | |
| WHO grade and 1p/19q | |||
| II | Codeleted | 7 (1.5%) | 41.4 ± 10.8 |
| Non-codeleted | 25 (5.4%) | 48.1 ± 14.6 | |
| III | Codeleted | 41 (8.9%) | 42.2 ± 9.3 |
| Non-codeleted | 101 (21.8%) | 47.1 ± 14.9 | |
| IV | Codeleted | 8 (1.7%) | 54.6 ± 16.7 |
| Non-codeleted | 281 (60.7%) | 56.1 ± 14.1 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
